Fertility preservation and reproduction in patients facing gonadotoxic therapies a committee opinion

Ethical considerations of preserving fertility after gonadotoxic treatment are discussed.

Like Comment

Authors

Ethics Committee of the American Society for Reproductive Medicine

Volume 100, Issue 5, Pages 1224-1231, November 2013

Abstract

Chemotherapy and radiation therapy often result in reduced fertility, and patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. Reproduction in the context of cancer also raises a number of ethical issues related to the welfare of both patients and offspring. This document replaces the document titled, “Fertility preservation and reproduction in cancer patients,” last published in 2005 (Fertil Steril 2005;83:1622–8).

Earn online CME credit related to this document at www.asrm.org/elearn

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)03007-0/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.